Skip to main content
Premium Trial:

Request an Annual Quote

Ren Bernards, Claire Fraser, Alejandro Zaffaroni

Premium

René Bernards, chief scientific officer of Agendia, has won the Spinoza prize from the Dutch Organization for Scientific Research, Agendia said today. He also heads the division of molecular carcinogenesis at the Netherlands Cancer Institute.


Claire Fraser has won the 2005 Promega Biotechnology Research Award, the Institute for Genomic Research said this week. She is the president and director, as well as a co-founder, of Rockville, Md.-based TIGR. Fraser, who received the award on Monday at the general meeting of the American Society for Microbiology in Atlanta, is honored for her "outstanding contributions and research to the application of biotechnology through fundamental microbiological research and development." She holds a PhD in pharmacology from the State University of New York at Buffalo and a BS in biology from Rensselaer Polytechnic Institute in New York.


Alejandro Zaffaroni last month received the Gregory Pincus Award from the Worcester Foundation for Biological Research "for his visionary leadership in developing technologies and products ..., as well as his success in commercializing novel techniques for drug discovery and drug delivery."

The Uruguayan-born founder of Alza also co-founded Affymetrix, Perlegen Sciences, Dnax, Affymax, Symyx Technologies, Maxygen, SurroMed, and, most recently, Alexza MDC. Zaffaroni received holds a PhD in biochemistry from the University of Rochester and a BS from the University of Montevideo in Uruguay.

The Pincus award, established in 1969, is given annually by the Worcester Foundation at the University of Massachusetts Medical Center to recognize individuals who are pioneers in the fields of endocrine and reproductive biology.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.